Logo image of AX

AXOS FINANCIAL INC (AX) Stock Fundamental Analysis

NYSE:AX - New York Stock Exchange, Inc. - US05465C1009 - Common Stock - Currency: USD

85.07  -0.83 (-0.97%)

After market: 85.07 0 (0%)

Fundamental Rating

3

Overall AX gets a fundamental rating of 3 out of 10. We evaluated AX against 392 industry peers in the Banks industry. While AX is still in line with the averages on profitability rating, there are concerns on its financial health. AX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

AX had positive earnings in the past year.
AX had a positive operating cash flow in the past year.
Each year in the past 5 years AX has been profitable.
AX had a positive operating cash flow in 4 of the past 5 years.
AX Yearly Net Income VS EBIT VS OCF VS FCFAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

1.2 Ratios

AX's Return On Assets of 1.78% is amongst the best of the industry. AX outperforms 95.15% of its industry peers.
AX has a better Return On Equity (16.40%) than 95.41% of its industry peers.
Industry RankSector Rank
ROA 1.78%
ROE 16.4%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AX Yearly ROA, ROE, ROICAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

AX has a Profit Margin of 34.77%. This is amongst the best in the industry. AX outperforms 91.33% of its industry peers.
AX's Profit Margin has improved in the last couple of years.
AX does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 34.77%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y0.98%
PM growth 5Y1.75%
GM growth 3YN/A
GM growth 5YN/A
AX Yearly Profit, Operating, Gross MarginsAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

2

2. Health

2.1 Basic Checks

AX does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for AX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
AX Yearly Shares OutstandingAX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
AX Yearly Total Debt VS Total AssetsAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

The Debt to FCF ratio of AX is 1.59, which is an excellent value as it means it would take AX, only 1.59 years of fcf income to pay off all of its debts.
AX has a Debt to FCF ratio (1.59) which is in line with its industry peers.
A Debt/Equity ratio of 0.19 indicates that AX is not too dependend on debt financing.
AX has a Debt to Equity ratio (0.19) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.59
Altman-Z N/A
ROIC/WACCN/A
WACC17.23%
AX Yearly LT Debt VS Equity VS FCFAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
AX Yearly Current Assets VS Current LiabilitesAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

4

3. Growth

3.1 Past

AX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.24%.
The Earnings Per Share has been growing by 20.06% on average over the past years. This is a very strong growth
The Revenue has been growing slightly by 6.31% in the past year.
AX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.74% yearly.
EPS 1Y (TTM)-3.24%
EPS 3Y23.4%
EPS 5Y20.06%
EPS Q2Q%6.67%
Revenue 1Y (TTM)6.31%
Revenue growth 3Y20.44%
Revenue growth 5Y16.74%
Sales Q2Q%10.49%

3.2 Future

The Earnings Per Share is expected to grow by 9.13% on average over the next years. This is quite good.
Based on estimates for the next years, AX will show a small growth in Revenue. The Revenue will grow by 7.38% on average per year.
EPS Next Y7.87%
EPS Next 2Y9.13%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.58%
Revenue Next 2Y7.38%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AX Yearly Revenue VS EstimatesAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B
AX Yearly EPS VS EstimatesAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.40, which indicates a very decent valuation of AX.
Compared to the rest of the industry, the Price/Earnings ratio of AX is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 26.99. AX is valued rather cheaply when compared to this.
AX is valuated reasonably with a Price/Forward Earnings ratio of 10.57.
AX's Price/Forward Earnings ratio is in line with the industry average.
AX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.36.
Industry RankSector Rank
PE 11.4
Fwd PE 10.57
AX Price Earnings VS Forward Price EarningsAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

AX's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. AX is more expensive than 62.76% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.58
EV/EBITDA N/A
AX Per share dataAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

AX's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.45
PEG (5Y)0.57
EPS Next 2Y9.13%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for AX!.
Industry RankSector Rank
Dividend Yield N/A

AXOS FINANCIAL INC

NYSE:AX (8/6/2025, 8:09:38 PM)

After market: 85.07 0 (0%)

85.07

-0.83 (-0.97%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)10-28 2025-10-28/amc
Inst Owners83.55%
Inst Owner Change-0.29%
Ins Owners9.53%
Ins Owner Change-1.42%
Market Cap4.80B
Analysts84.29
Price Target101.32 (19.1%)
Short Float %4.88%
Short Ratio7.74
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.6%
Min EPS beat(2)-0.08%
Max EPS beat(2)1.28%
EPS beat(4)2
Avg EPS beat(4)0.74%
Min EPS beat(4)-3.64%
Max EPS beat(4)5.42%
EPS beat(8)5
Avg EPS beat(8)13.36%
EPS beat(12)7
Avg EPS beat(12)8.22%
EPS beat(16)10
Avg EPS beat(16)6.68%
Revenue beat(2)0
Avg Revenue beat(2)-1.63%
Min Revenue beat(2)-1.71%
Max Revenue beat(2)-1.55%
Revenue beat(4)0
Avg Revenue beat(4)-2.77%
Min Revenue beat(4)-5.9%
Max Revenue beat(4)-1.55%
Revenue beat(8)3
Avg Revenue beat(8)3.44%
Revenue beat(12)7
Avg Revenue beat(12)3.78%
Revenue beat(16)8
Avg Revenue beat(16)2.29%
PT rev (1m)9.86%
PT rev (3m)9.83%
EPS NQ rev (1m)-1.92%
EPS NQ rev (3m)-0.46%
EPS NY rev (1m)-0.52%
EPS NY rev (3m)1.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.17%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.31%
Valuation
Industry RankSector Rank
PE 11.4
Fwd PE 10.57
P/S 3.9
P/FCF 15.58
P/OCF 13.67
P/B 1.84
P/tB 1.97
EV/EBITDA N/A
EPS(TTM)7.46
EY8.77%
EPS(NY)8.05
Fwd EY9.46%
FCF(TTM)5.46
FCFY6.42%
OCF(TTM)6.22
OCFY7.31%
SpS21.79
BVpS46.19
TBVpS43.29
PEG (NY)1.45
PEG (5Y)0.57
Profitability
Industry RankSector Rank
ROA 1.78%
ROE 16.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 34.77%
GM N/A
FCFM 25.06%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y0.98%
PM growth 5Y1.75%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.59
Debt/EBITDA N/A
Cap/Depr 148.85%
Cap/Sales 3.49%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 72.08%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC17.23%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.24%
EPS 3Y23.4%
EPS 5Y20.06%
EPS Q2Q%6.67%
EPS Next Y7.87%
EPS Next 2Y9.13%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.31%
Revenue growth 3Y20.44%
Revenue growth 5Y16.74%
Sales Q2Q%10.49%
Revenue Next Year4.58%
Revenue Next 2Y7.38%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y4.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6.12%
OCF growth 3YN/A
OCF growth 5YN/A